In the last trading session, 2.02 million shares of the TNF Pharmaceuticals Inc (NASDAQ:TNFA) were traded, and its beta was 2.15. Most recently the company’s share price was $0.19, and it changed around -$0.01 or -3.73% from the last close, which brings the market valuation of the company to $1.96M. TNFA currently trades at a discount to its 52-week high of $3.37, offering almost -1673.68% off that amount. The share price’s 52-week low was $0.16, which indicates that the current value has risen by an impressive 15.79% since then.

TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information

Instantly TNFA has showed a red trend with a performance of -3.73% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2386 on recent trading dayincreased the stock’s daily price by 20.37%. The company’s shares are currently down -83.16% year-to-date, but still down -13.06% over the last five days. On the other hand, TNF Pharmaceuticals Inc (NASDAQ:TNFA) is -52.07% down in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 50.65%.

TNFA Dividends

TNF Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in June.

VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 13.69 shares worth $2651.0, making up 0.14% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 11.21 shares worth around $2171.0, which represents about 0.11% of the total shares outstanding.